UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis

International journal of molecular sciences, 2022-11, Vol.23 (22), p.14378

2022

Volltextzugriff (PDF)

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis

Neurotherapeutics, 2021-04, Vol.18 (2), p.920-937

2021

Volltextzugriff (PDF)

Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis

Neurobiology of disease, 2020-09, Vol.143, p.104994-104994, Article 104994

2020

Volltextzugriff (PDF)

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review

Frontiers in cellular neuroscience, 2020-02, Vol.14, p.34-34

2020

Volltextzugriff (PDF)

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

Glia, 2012-09, Vol.60 (9), p.1437-1450

2012

Volltextzugriff (PDF)

Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis

Journal of neuroinflammation, 2020-03, Vol.17 (1), p.88-88, Article 88

2020

Volltextzugriff (PDF)

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis

Frontiers in immunology, 2019-06, Vol.10, p.1374-1374

2019

Volltextzugriff (PDF)

2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs

Glia, 2018-07, Vol.66 (7), p.1447-1463

2018

Volltextzugriff (PDF)

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system

Current pharmaceutical design, 2014-01, Vol.20 (29), p.4707

2014

Volltextzugriff (PDF)

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

Journal of neuroinflammation, 2018-03, Vol.15 (1), p.64-64, Article 64

2018

Volltextzugriff (PDF)

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

Gut microbes, 2020-11, Vol.12 (1), p.1813532-1813532

2020

Volltextzugriff (PDF)

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

Cells (Basel, Switzerland), 2020-04, Vol.9 (4), p.906

2020

Volltextzugriff (PDF)

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells

Brain, behavior, and immunity, 2011-05, Vol.25 (4), p.736-749

2011

Volltextzugriff (PDF)

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

The European journal of neuroscience, 2008-08, Vol.28 (4), p.633-641

2008

Volltextzugriff (PDF)

Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling

British journal of pharmacology, 2005-06, Vol.145 (4), p.441-448

2005

Volltextzugriff (PDF)

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

Pharmaceutics, 2022-07, Vol.14 (7), p.1420

2022

Volltextzugriff (PDF)

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors

Journal of neuroinflammation, 2011-08, Vol.8 (1), p.102-102

2011

Volltextzugriff (PDF)

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

Neurobiology of disease, 2005-11, Vol.20 (2), p.207-217

2005

Volltextzugriff (PDF)

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE

Journal of Immunology Research, 2014-01, Vol.2014, p.156380-10

2014

Volltextzugriff (PDF)

Activation of cannabinoid CB 2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling

British journal of pharmacology, 2009-01, Vol.145 (4), p.441-448

2009

Volltextzugriff (PDF)

Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus

Progress in neurobiology, 2013-02, Vol.101-102, p.46-64

2013

Volltextzugriff (PDF)

Anandamide enhances IL-10 production in activated microglia by targeting CB2 receptors: Roles of ERK1/2, JNK, and NF-κB

Glia, 2010-01, Vol.58 (2), p.135-147

2010

Volltextzugriff (PDF)

Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis

Aging cell, 2021-09, Vol.20 (9), p.e13440-n/a

2021

Volltextzugriff (PDF)

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination

The Journal of neuroscience, 2017-08, Vol.37 (35), p.8385-8398

2017

Volltextzugriff (PDF)

2‐arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions

Glia, 2020-06, Vol.68 (6), p.1255-1273

2020

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis

Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis

2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE

Activation of cannabinoid CB 2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling

Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus

Anandamide enhances IL-10 production in activated microglia by targeting CB2 receptors: Roles of ERK1/2, JNK, and NF-κB

Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination

2‐arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions

Suchergebnisse filtern